A tetramer with lipids buried at its interfaces
The study solved cryo-electron microscopy structures of full-length human PLPP1 in two states: an apo state at 1.87 Å overall resolution and a product-bound state at 2.21 Å, the latter obtained after incubating the protein with LPA. Both maps show four protomers arranged around a central axis with C4 symmetry, each protomer built from six transmembrane helices (TM1–TM6) plus short extracellular loops and minimal cytoplasmic extensions. All four catalytic domains face the extracellular space, matching PLPP1's role as an ecto-phosphatase that removes phosphate from extracellular lipid phosphates.
The 1.87 Å map also resolved non-protein densities inside the transmembrane region. On the basis of shape and local chemical environment, the authors modeled three of them as phosphatidylcholine (PC), phosphatidic acid (PA) and phosphatidylinositol-4,5-bisphosphate (PIP2), and they also resolved ordered water molecules. These densities sit in discrete inter-subunit sites and membrane-facing grooves rather than at the catalytic center. The paper is explicit that the structures alone do not establish that these lipids are required for tetramer formation.
Three lipid sites occupy different membrane depths
The three modeled lipids are spatially segregated, which is the observation most likely to be confused with a functional claim. PC sits at an inter-subunit site near the membrane midplane and extracellular boundary, wedged between TM3 and TM6 of one protomer and TM5 and TM6 of its neighbor. Its phosphocholine headgroup is anchored by electrostatic contacts with D42 and E43 and by R125, with a water-mediated hydrogen-bond network involving S44, H224 and Y47; its acyl chains are buried against L123, F167 and Y168 on one side and I211, L215, W225, L229 and L232 on the other. Because this site is separated from the catalytic motifs, the authors read it as structural rather than catalytic.
PA occupies a second site at the cytoplasmic leaflet, at the junction of TM3 and TM6 of one protomer with TM4, TM5 and TM6 of the other. Its phosphate headgroup hydrogen bonds to Q187 and interacts electrostatically with K191, while acyl chains pack against F106, V238, L241 and Y245 plus L84, L180, V207, I240 and F250. PIP2 sits at a peripheral cytoplasmic site, its highly charged inositol bisphosphate headgroup held in a cationic pocket formed by R6, K100, K251 and R253 from one protomer and R196 from the other, with a hydrogen bond from D193 to the glycerol backbone. The paper states directly that the present data do not establish non-equivalent or hierarchical contributions of the individual lipids to tetramerization or activity.
Activity loss and tetramer loss do not track together
To test whether residues around these lipid sites matter, the authors made structure-guided point mutants and measured phosphate release. Four substitutions — F167A, H224A, W225A and K100A — dropped the absorbance-based activity signal to near the assay control, while Y47A, R125A, Y99A, K251A and R253A had more moderate effects. The informative part is what happened to assembly: in-gel RFP fluorescence showed that Y47A and R125A reduced the apparent tetrameric population yet retained substantial phosphatase activity, whereas F167A, H224A, W225A and K100A kept substantial higher-order species despite strongly reduced activity.
That dissociation is the paper's key caution against a simple model in which tetramerization is required for catalysis. The authors conclude that activity loss does not simply correlate with tetramer disruption. It also means the interfacial lipid sites cannot be read as a straightforward on/off switch from these data: the mutants perturb residues near the lipids, but the assay separates enzymatic output from oligomeric state rather than proving that a given lipid is needed for either.
The product-bound state defines the catalytic pocket
The LPA-incubated structure places reaction products in the active sites: inorganic phosphate (Pi) and monoacylglycerol (MAG) are assigned as products, with an additional bound lipid assigned as phosphatidylethanolamine (PE). Pi is coordinated by conserved residues, and ordered water molecules plus conserved electrostatic interactions position the phosphate for what the authors describe as a histidine-mediated phosphotransfer mechanism, with the geometry consistent with in-line nucleophilic attack. Superposition of the apo and product-bound structures shows no substantial overall or local conformational change, so the enzyme appears to act without a large rearranging motion.
The same structure reveals a membrane-facing tunnel leading to the catalytic center, which the authors propose as a possible lateral route for LPA to reach the active site from within the membrane. They further suggest the tunnel's geometry may help discriminate mono-acyl signaling lipids from bulkier membrane phospholipids. Both points are framed as suggestions from the structure, not as demonstrated transport or selectivity measurements.
Kinetics set a baseline for judging mutants
Purified PLPP1 hydrolyzed LPA with an apparent Km of 147.9 ± 15.8 µM and an apparent kcat of 54.0 ± 3.9 s⁻¹, from Michaelis–Menten analysis. Against that baseline, substituting the catalytic histidine (H171A) or residues coordinating the phosphate (K120A, R127A, S169A, R217A and H223A) reduced the activity signal to near the assay control, and mutation of E162 substantially reduced turnover. These are the residues that define the chemistry of phosphate removal, distinct from the interfacial residues tested for assembly effects.
Keeping the two mutant sets apart matters for readers: the catalytic-site mutants address how the phosphate is hydrolyzed, while the interfacial mutants address how the surrounding assembly and lipid environment relate to activity. The paper does not report a single mechanism that unifies both sets, and the kinetic constants are apparent values measured on purified protein in detergent, not cellular rates.
The central cavity does not conduct ions in these tests
The tetramer creates a prominent central cavity spanning the membrane, which invites the question of whether it forms a pore. Electrophysiological recordings with whole-cell currents evoked by 500 ms voltage steps from −100 to +100 mV, in 20 mV increments, detected no PLPP1-associated ion conductance under the conditions tested, including recordings under phosphate-containing bath and pipette solutions. The authors connect this to the hydrophobic, lipid-occluded middle of the cavity.
This is a negative result bounded by its conditions: it rules out a detectable conductance in the assays used, not the existence of any transport function under other conditions. It does, however, argue against reading the tetramer's central axis as an open channel on the basis of the structure alone.
What the tetramer framework leaves open
The paper positions its contribution as a structural framework for PLPP1 assembly, interfacial lipid interactions, product recognition and catalysis, and it is careful about the boundaries. It does not show that PC, PA or PIP2 is required for tetramer formation, nor that the three lipids make distinct functional contributions. The comparison with prokaryotic homologues such as E. coli PgpB is architectural: individual protomers are the closest matches, but those enzymes form dimers with r.m.s.d. values exceeding 10 Å, so tetramerization is a distinct feature of human PLPP1 among the homologues examined.
The authors also raise, without testing, the possibility that differences in lipid-binding landscapes, oligomerization propensity or membrane microdomain association could help explain why PLPP1, PLPP2 and PLPP3 have non-redundant roles in vivo despite conserved catalytic motifs and broad in vitro substrate specificity. That would require direct comparison of additional isoforms. Similarly, the relevance to PLPP1's reported role as a metabolic checkpoint in tumor-infiltrating CD8+ T cells is presented as a framework for future work, not as a result of this study.
Read the lipid sites as organization, not switches
The most decision-relevant takeaway is a comparison inside the paper: mutants that weaken the apparent tetramer (Y47A, R125A) can retain substantial phosphatase activity, while mutants that keep higher-order species (F167A, H224A, W225A, K100A) can lose activity almost entirely. For anyone using these structures to reason about PLPP1, that ordering means interfacial lipid densities and tetramer integrity should be treated as contributors to local organization of the assembly, not as a gate that must be closed for catalysis to occur.
The product-bound catalytic pocket and the LPA-facing tunnel are the parts of the model with the clearest mechanistic content: they specify which residues coordinate phosphate, give apparent Km and kcat values for LPA hydrolysis, and propose a lateral access route. The lipid assignments at the interfaces remain structural observations whose individual necessity is untested, and the absence of ion conductance holds only for the recording conditions used. The paper's own priority for follow-up is therefore the contribution of individual lipids and oligomeric states to enzyme function, not a claim that the tetramer alone explains lipid phosphate signaling.
Sources used in this answer
Lipid-organized tetramerization of PLPP1 defines the molecular basis of spatial lipid phosphate signaling
Cryo-EM structures of human PLPP1 at 1.87 Å (apo) and 2.21 Å (product-bound) reveal a C4-symmetric homotetramer with interfacial lipid densities assigned to PC, PA and PIP2; mutagenesis shows activity loss does not simply correlate with tetramer disruption.